NRG-HN005 is a clinical study for people with Human Papillomavirus (HPV) positive oropharyngeal cancer. This study has two parts called “phase II” and “phase III”.
Typically, people with your type of cancer are treated with radiation therapy and chemotherapy, also known as the “usual approach”. For patients who get the usual approach for this cancer, about 88 out of 100 are free of cancer after 5 years.
Researchers are doing this study to find out if a reduced dose of radiation and immunotherapy results in at least a similar length of time without your cancer getting worse and a better quality of life than the usual approach.
More information about this particular study is located on ClinicalTrials.gov
Are you interested in joining the study? Find a participating location
Below, you can find FAQs about clinical research and this particular clinical trial.
Talk to your insurance provider and make sure that you understand what your insurance pays for and what it does not pay for if you take part in this clinical trial. Also, find out if you need approval from your plan before you can take part in the study.
You will not be paid for taking part in this study.
Doctors and researchers conduct a clinical study, also called a “clinical trial,” to find better ways to prevent, diagnose, or treat an illness. NRG Oncology is supported by the National Cancer Institute (NCI) and runs clinical studies specifically for patients with cancer or to prevent cancer. Most clinical studies test something we know against something we don’t know. In all situations, these studies are strictly evaluated before they are allowed to be offered to any patient. The study is designed to answer the question that we do not know the answer to, so that current and future patients may have better treatments or information than what we currently have. There are different types of clinical studies that might be available for patients. For more information see “Types of Clinical Trials” and “Phases of Clinical Trials”.
Patients who volunteer to take part in a clinical study are followed closely by their health care professionals and members of the research team. For more information see “Research Team Members”.
At NRG Oncology, we focus on conducting clinical studies aimed to improve current cancer care practices and the lives of cancer patients. NRG Oncology partners with more than 1,300 member sites world-wide to research ways to improve treatment standards in the cancer community. Our organization is supported primarily through grants from the National Cancer Institute (NCI) and is one of five research groups in the NCI's National Clinical Trial's Network.